Company profile: IDEA Pharma
1.1 - Company Overview
Company description
- Provider of strategic marketing, portfolio and disease area strategy, positioning, scenario planning and communication strategy for pharmaceutical companies, including path-to-market strategies addressing clinical, regulatory and commercial challenges; innovation strategy; strategic pharmaceutical positioning; Immersion, Design, Evaluation, Acceleration insights; and the annual Pharmaceutical Innovation and Invention Index.
Products and services
- Innovation Strategy: Architects evidence-based frameworks that apply insights to improve decision-making processes for delivering pharmaceutical innovations to patients
- Path to Market Strategy: Engineers regulatory-grade strategies that navigate clinical, regulatory, and commercial challenges for bringing a pharmaceutical product to market, integrating actions across these domains
- Strategic Pharmaceutical Positioning: Creates custom-engineered positioning that defines how a pharmaceutical product will be perceived in the market, emphasizing future messaging and market leadership to anchor communication strategy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IDEA Pharma
Noramco
HQ: United States
Website
- Description: Provider of design, construction, and management services for bulk active pharmaceutical ingredient plants, including a Wilmington, Delaware facility supporting Ortho-McNeil Pharmaceutical's Tylenol with codeine business; expanded through the acquisition of Tasmanian Alkaloids and the addition of an Athens, Georgia site in 1982.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noramco company profile →
ADVI Health
HQ: United States
Website
- Description: Provider of boutique health care advisory services, including market access and pricing strategy; federal and state policy monitoring and modeling; strategic analytics, value and economics; coding and reimbursement for Medicare, Medicaid, VA-DOD, and private payers; and data-driven financial services due diligence to quantify risks, opportunities, and trends.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ADVI Health company profile →
Concept Life Sciences
HQ: United Kingdom
Website
- Description: Provider of scientific laboratory and consulting services, offering integrated drug discovery and development; molecular biology (gene expression analysis, transcriptomics, genetic modification); protein production; spatial and structural biology; ADME & DMPK assays; and analytical testing and environmental consulting for pharmaceutical, biotechnology, agrochemical, and environmental sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Concept Life Sciences company profile →
Nexelis
HQ: United States
Website
- Description: Provider of assay development and advanced laboratory testing; a portfolio company of Ampersand Capital Partners.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nexelis company profile →
Phaxiam Therapeutics
HQ: France
Website
- Description: Provider of bacteriophage-based therapies to combat antimicrobial-resistant bacterial infections, offering phage treatments, GMP individualized phage therapies (IPT), standardized phage therapies medicinal products (PTMP), a phage portfolio targeting Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, an in vitro Phagogram test for phage susceptibility, and PhagoDAIR clinical trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phaxiam Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IDEA Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IDEA Pharma
2.2 - Growth funds investing in similar companies to IDEA Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IDEA Pharma
4.2 - Public trading comparable groups for IDEA Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →